BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 9, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it has appointed Brian Blaser to its Board of Directors effective as of January 6, 2023 . Mr.

New CLIA blood test expands access to important “brain health” biomarker to advance research and clinical care BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 9, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive

BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 3, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will be presenting at the 41 st Annual J.P.